Related Experiment Videos
A new antitumor antibiotic, FR900840. I. Discovery, identification, isolation and characterization
M Nishimura1, H Nakada, H Nakajima
1Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Ibaraki, Japan.
The Journal of Antibiotics
|April 1, 1989
Abstract:
A new antitumor antibiotic, FR900840, was isolated from a culture broth of Streptomyces strain No. 8727 as a pale yellowish prism and the molecular formula was determined to be C7H11N3O5. The antibiotic exhibited prominent antitumor effects on human tumor cell lines both in vitro and in vivo.
Insights
A novel antitumor antibiotic, FR900840, was discovered from Streptomyces strain No. 8727. This compound shows significant antitumor activity against human cancer cell lines in laboratory and living organism studies.
Area of Science:
- Microbiology
- Pharmacology
- Organic Chemistry
Background:
- The search for novel antimicrobial agents is crucial for combating drug-resistant pathogens.
- Streptomyces species are a prolific source of bioactive natural products with therapeutic potential.
Purpose of the Study:
- To isolate and characterize a new antitumor antibiotic from Streptomyces strain No. 8727.
- To evaluate the antitumor efficacy of the novel compound FR900840.
Main Methods:
- Isolation of the antibiotic FR900840 from the culture broth of Streptomyces strain No. 8727.
- Determination of the molecular formula (C7H11N3O5) using analytical techniques.
- In vitro and in vivo testing of antitumor activity against human tumor cell lines.
Main Results:
- A new antitumor antibiotic, designated FR900840, was successfully isolated.
- The molecular formula of FR900840 was identified as C7H11N3O5.
- FR900840 demonstrated significant antitumor effects on human tumor cell lines in both in vitro and in vivo models.
Conclusions:
- FR900840 is a promising new antitumor agent derived from microbial sources.
- Further investigation into the mechanism of action and therapeutic potential of FR900840 is warranted.